Nurexone Biologic Shows Preclinical Spinal Cord Repair with Exopten
NurExone Biologic Inc. has released new preclinical MRI-DTI (Diffusion Tensor Imaging) data for ExoPTEN, its exosome-based therapy for spinal...
Hutchmed Completes Patient Enrollment for Orpathys®-Tagrisso® Lung Cancer Trial in China
Hutchmed has completed enrollment in its China Phase 3 SANOVO trial, evaluating the combination of savolitinib (Orpathys) and osimertinib...
Hutchmed Enrolls First-Line Lung Cancer Patients in China Trial
HUTCHMED has completed enrollment in its China Phase III SANOVO trial evaluating savolitinib plus osimertinib as a first-line treatment...
Cour Pharma Doses First Patient in CNP-103 Trial for Type 1 Diabetes
COUR Pharma has dosed the first patient in a Phase 1b/2a trial of CNP-103, a tolerogenic nanoparticle therapy for...
ALX Oncology Doses First Patient in Phase 1 Trial of ALX1004
ALX Oncology has initiated a Phase 1 trial of ALX2004, an epidermal growth factor receptor (EGFR) antibody-drug conjugate (ADC),...
Capricor Doses First Subjects in Phase 1 Exosome Vaccine Trial
Capricor Therapeutics has initiated a Phase 1 trial of its StealthX™ exosome-based vaccine platform. The trial, funded by the...
Biodexa Initiates Phase 3 Serenta Trial for Familial Adenomatous Polyposis
Biodexa has initiated its pivotal Phase 3 Serenta trial of eRapa in patients with familial adenomatous polyposis (FAP). The...
Ascentage Pharma’s Lisaftoclax Enters Phase III Trial for Myelodysplastic Syndrome
Ascentage Pharma has secured both FDA and EMA clearance for its global Phase 3 GLORA-4 trial evaluating lisaftoclax, a...
Simplifying EUCTR Disclosure: Veeva’s Unified Platform Tackles Complexity
At the 2025 Veeva R&D and Quality Summit in Madrid, Matt DeFranco, Senior Director of Disclosure Strategy at Veeva...
Jabez BioSciences Opens Second Site in Oncology Study
Jabez Biosciences has opened a second clinical site for its Phase 1 trial of JBZ-001, a dihydroorotate dehydrogenase (DHODH)...